[Tumor markers in breast neoplasm].
Breast cancer is the most frequently diagnosed cancer among women in the western world. In spite of a great deal of scientific information in relation to its origin, of new diagnostic methods and treatments, mortality rate due to breast cancer has virtually remained stable over the past 20 years. Recent advances in molecular biology have improved the understanding of the basic biology of breast cancer. This fact has led to the identification of new tumor markers the ultimate goal of which is to reduce mortality by identifying women at risk as well as predicting the prognosis of existing disease and the response to different therapies. This article focuses on both traditional and new molecular markers, their clinical utility and their relevance in the routine evaluation of patients with breast cancer.
Coronato
Silvia
S
Cátedra de Patología B, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina. scorona@atlas.med.unlp.edu.ar
Laguens
Graciela E
GE
Spinelli
Osvaldo M
OM
Di Girolamo
Wanda
W
D014408:Biomarkers, Tumor / Q000097:blood / Q000145:classification* / Q000235:genetics; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D005819:Genetic Markers; D006801:Humans
D014408:Biomarkers, Tumor; D005819:Genetic Markers